Zhiqiang Shu
Stock Analyst at Berenberg
(0.08)
# 4,248
Out of 4,876 analysts
7
Total ratings
14.29%
Success rate
-21.07%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Zhiqiang Shu
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IDYA IDEAYA Biosciences | Initiates: Buy | $26 | $21.37 | +21.67% | 1 | Mar 23, 2023 | |
| BPMC Blueprint Medicines | Initiates: Buy | $90 | $128.11 | -29.75% | 1 | Sep 14, 2022 | |
| STRO Sutro Biopharma | Initiates: Buy | $30 | $0.73 | +3,987.19% | 1 | Nov 17, 2021 | |
| SNSE Sensei Biotherapeutics | Downgrades: Hold | $240 | $8.68 | +2,664.98% | 1 | Jul 1, 2021 | |
| NRIX Nurix Therapeutics | Initiates: Buy | n/a | $11.64 | - | 1 | Apr 14, 2021 | |
| STTK Shattuck Labs | Initiates: Buy | $47 | $0.85 | +5,405.45% | 1 | Apr 14, 2021 | |
| RPTX Repare Therapeutics | Initiates: Buy | $51 | $1.38 | +3,595.65% | 1 | Mar 1, 2021 |
IDEAYA Biosciences
Mar 23, 2023
Initiates: Buy
Price Target: $26
Current: $21.37
Upside: +21.67%
Blueprint Medicines
Sep 14, 2022
Initiates: Buy
Price Target: $90
Current: $128.11
Upside: -29.75%
Sutro Biopharma
Nov 17, 2021
Initiates: Buy
Price Target: $30
Current: $0.73
Upside: +3,987.19%
Sensei Biotherapeutics
Jul 1, 2021
Downgrades: Hold
Price Target: $240
Current: $8.68
Upside: +2,664.98%
Nurix Therapeutics
Apr 14, 2021
Initiates: Buy
Price Target: n/a
Current: $11.64
Upside: -
Shattuck Labs
Apr 14, 2021
Initiates: Buy
Price Target: $47
Current: $0.85
Upside: +5,405.45%
Repare Therapeutics
Mar 1, 2021
Initiates: Buy
Price Target: $51
Current: $1.38
Upside: +3,595.65%